HomeMarket NewsStifel Initiates Coverage on MoonLake Immunotherapeutics as an Attractive M&A Target with...

Stifel Initiates Coverage on MoonLake Immunotherapeutics as an Attractive M&A Target with Strong Potential

Actionable Trade Ideas

always free

Medical form with diagnosis psoriatic arthritis on a table.


Stifel, a leading financial services firm, recently initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) and assigned it a buy rating. The firm predicts significant potential upside for MoonLake through the de-risking of its flagship drug, sonelokimab, in additional indications and/or potential M&A opportunities.

The analysts at Stifel consider MoonLake to be among the most de-risked clinical-stage companies in the inflammation and immunology (I&I) space, providing a β€œclear path to a blockbuster drug.” They estimate that sonelokimab could generate around $4.2 billion in US revenue, primarily targeting the hidradenitis suppurativa and psoriatic arthritis markets, while other indications could offer additional upside.

Stifel further emphasized the potential value of sonelokimab, stating, β€œWe believe sonelokimab could be a $4 billion+ drug, and recent acquisitions in the I&I sector, such as Nimbus, RXDX, and Telavant, suggest that strategic buyers are willing to pay a premium for de-risked Phase 3-ready assets.”

As part of their coverage, Stifel set a price target of $74 for MoonLake Immunotherapeutics’s stock, highlighting their confidence in its future growth prospects.

Keywords: MoonLake Immunotherapeutics, Stifel, buy rating, de-risking, sonelokimab, drug, M&A, inflammation and immunology, I&I, blockbuster drug, hidradenitis suppurativa, psoriatic arthritis, potential upside, US revenue, acquisitions, strategic buyers, Phase 3-ready assets, price target $74, stock.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.